NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
3.290
+0.110 (3.46%)
Nov 20, 2024, 4:00 PM EST - Market closed
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $6.24 million as of November 21, 2024. Its market cap has decreased by -71.45% in one year.
Market Cap
6.24M
Enterprise Value
7.40M
1-Year Change
-71.45%
Ranking
Category
Stock Price
$3.29
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $6.24M, a decrease of -68.97%. That is a compound annual growth rate of -26.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 6.03M | -68.46% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
| Jan 29, 2021 | 20.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongchao | 6.38M |
| ABVC BioPharma | 6.30M |
| CNS Pharmaceuticals | 6.29M |
| Alzamend Neuro | 6.27M |
| Cutera | 6.13M |
| Viracta Therapeutics | 6.03M |
| Xenetic Biosciences | 6.01M |
| Biora Therapeutics | 5.99M |